Journals / Ankara Üniversitesi Tıp Fakültesi Mecmuası / 2015 / Cilt: 68 - Sayı: 2

The Area of Usage of the Vitamin D in Different Diseases and Unknown Benefits

D Vitamininin Çesitli Hastalıklardaki Nadir Kullanım Alanları

Pages
55–63
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We aimed to review non-routine usages of vitamin D and obtained results.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vitamin D regulates the serum calcium and phosphorus levels by effecting absorption and metabolism of these minerals.
📊
Key Findings & Data:Since determining the vitamin D reseptors are expressed in many tissue and cells, non-clasical effects of vitamin D was begun to be investigated.
💡
Conclusion & Impact:We aimed to review non-routine usages of vitamin D and obtained results.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Vitamin D regulates the serum calcium and phosphorus levels by effecting absorption and metabolism of these minerals. Since determining the vitamin D reseptors are expressed in many tissue and cells, non-clasical effects of vitamin D was begun to be investigated. Promising results with non-hypercalcemic doses of vitamin D are available in many diseases such as diabetes mellitus, multiple sclerosis, amyotrophic lateral sclerosis and metabolic syndrome. Additionally the patient selection, risk factors and doses of the vitamin are uncertain. We aimed to review non-routine usages of vitamin D and obtained results.

Özet

D vitamini, serum kalsiyum ve fosfor düzeylerini, emilim ve metabolizma üzerinden etkileyerek düzenler. D vitamini reseptörlerinin vücudun birçok doku ve hücresinde tespit edilmesiyle, klasik olmayan etkileri arastırılmaya baslanmıstır. Hiperkalsemik etkilerinin ortaya çıkmadığı dozlarda verilen vitamin ile diabetes mellitus, multipl skleroz, amyotrofik lateral skleroz, meta- bolik sendrom gibi birçok hastalıkta elde edilen umut veren sonuçlar mevcuttur. Bununla be- raber hangi hastalara ve risk faktörü olanlara hangi dozlarda önerileceği konusu belirsizdir. Bu derlememizde rutin kullanım alanları dısında D vitamini uygulamaları ve elde edilen sonuçları ayrı ayrı ele alınarak derlenmistir.

🔖

Cite This Article

GENÇ, A., SEVİM, D. G., ÖZEN, A. T., YILMAZ, G. (2022). The Area of Usage of the Vitamin D in Different Diseases and Unknown Benefits. Ankara Üniversitesi Tıp Fakültesi Mecmuası, Cilt: 68 - Sayı: 2, 55–63. https://ajindex.com/articles/443763

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Wranicz J, Szostak-Wegierek D. Health outcomes of vitamin D. Part I. characteristics and classic role. Roczniki Panstwowego Zakladu Higieny. 2014;65(3):179-84. PubMed PMID: 25247796
  2. Holick MF. Vitamin D deficiency. The New England journal of medicine. 2007;357(3):266-81. PubMed PMID: 17634462
  3. Holick MF, Binkley NC, BischoffFerrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The Journal of clinical endocrinology and metabolism. 2011;96(7):1911-30. PubMed PMID: 21646368
  4. Prietl B, Treiber G, Mader JK, Hoeller E, Wolf M, Pilz S, et al. High-dose cholecalciferol supplementation significantly increases peripheral CD4(+) Tregs in healthy adults without negatively affecting the frequency of other immune cells. European journal of nutrition. 2014;53(3):751-9. PubMed PMID: 23999998
  5. Malek HA, Shata A. Effect of a high dose of vitamin D on a rabbit model of atherosclerosis. International journal of immunopathology and pharmacology. 2014;27(2):195-201. PubMed PMID: 25004831
  6. Bas A, Lopez I, Perez J, Rodriguez M, Aguilera-Tejero E. Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2006;21(3):484-90. PubMed PMID: 16491297
  7. Haffner D, Hocher B, Muller D, Simon K, Konig K, Richter CM, et al. Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3. Journal of hypertension. 2005;23(5):1067-75. PubMed PMID: 15834294
  8. Li F, Liu P, Zhang X, Zhang Q, Tang S, Zhu M, et al. 1,25(OH)2D3-mediated amelioration of aortic injury in streptozotocin-induced diabetic rats. Inflammation. 2013;36(6):1334-43. PubMed PMID: 23813327
  9. Pittas AG, Dawson-Hughes B. Vitamin D and diabetes. The Journal of steroid biochemistry and molecular biology. 2010;121(1-2):425-9. PubMed PMID: 20304061. Pubmed Central PMCID: 2900448
  10. Wu-Wong JR, Nakane M, Ma J, Ruan X, Kroeger PE. Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis. 2006;186(1):20- 8. PubMed PMID: 16095599
  11. Zehnder D, Bland R, Chana RS, Wheeler DC, Howie AJ, Williams MC, et al. Synthesis of 1,25- dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. Journal of the